Search research articles
Contact Us
Filters
Showing results (611-620 of 818) with videos related to
Page
of 82
Sort By:
Diagnostic Microbiology and Infectious Disease
|
July 1, 1991
In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds
R N Jones, M S Barrett, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 1991
In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin ester
R N Jones, M E Erwin, M S Barrett, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1997
Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans
M E Klepser, E J Wolfe, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease
|
May 26, 1999
Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America)
G V Doern, R N Jones, M A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2001
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999
D J Hoban, G V Doern, A C Fluit, et al.
Diagnostic Microbiology and Infectious Disease
|
May 5, 2000
Comparison of oral immediate-release (IR) and extended-release (ER) metronidazole bactericidal activity against Bacteroides spp. using an in vitro model of infection
R E Lewis, M E Klepser, E J Ernst, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
November 4, 2000
Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98)
H S Sader, A C Gales, T D Granacher, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 2001
Cefditoren in vitro activity and spectrum: a review of international studies using reference methods
R N Jones, M A Pfaller, M R Jacobs, et al.
Journal of Clinical Microbiology
|
May 15, 1999
Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae
R N Jones, D J Biedenbach, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
February 6, 1999
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program
G V Doern, M A Pfaller, M E Erwin, et al.
Page
of 82
Search research articles
Search
Showing results (611-620 of 818) with videos related to
Sort By:
Page
of 82
Diagnostic Microbiology and Infectious Disease
|
July 1, 1991
In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds
R N Jones, M S Barrett, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 1991
In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin ester
R N Jones, M E Erwin, M S Barrett, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1997
Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans
M E Klepser, E J Wolfe, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease
|
May 26, 1999
Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America)
G V Doern, R N Jones, M A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2001
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999
D J Hoban, G V Doern, A C Fluit, et al.
Diagnostic Microbiology and Infectious Disease
|
May 5, 2000
Comparison of oral immediate-release (IR) and extended-release (ER) metronidazole bactericidal activity against Bacteroides spp. using an in vitro model of infection
R E Lewis, M E Klepser, E J Ernst, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
November 4, 2000
Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98)
H S Sader, A C Gales, T D Granacher, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 2001
Cefditoren in vitro activity and spectrum: a review of international studies using reference methods
R N Jones, M A Pfaller, M R Jacobs, et al.
Journal of Clinical Microbiology
|
May 15, 1999
Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae
R N Jones, D J Biedenbach, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
February 6, 1999
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program
G V Doern, M A Pfaller, M E Erwin, et al.
Page
of 82